GSTM1 and schistosomiasis: A previous systematic review of schistosomiasis-related morbidity (King et al. 2005) identified five studies evaluating the impact of praziquantel on Hb levels in hookworm-endemic areas; but two of these trials co-administered benzimidazole or metrifonate treatment.